Improving access to and efficiency of treatment for stroke within 12 hours of onset in Atlantic Canada

Not Applicable

Completed

• Conditions: Ischemic stroke; Circulatory System; Cerebral infarction

• Registration Number: ISRCTN11109800
• Lead Sponsor: Dalhousie University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-02
• Study Completion: 2024-04-30
• Last Update Posted: 9 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 258

Inclusion Criteria

1. Enrolled to participate in the improvement collaborative
2. Involved with acute stroke care of ischemic stroke patients

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of ischemic stroke patients treated with alteplase and endovascular thrombectomy using data from the Discharge Abstract Database at the end of the data collection periods.

Secondary Outcome Measures

Name	Time	Method
Measures are obtained from chart audits at the end of the data collection periods:<br>1. Door to needle time (time from arrival to start of alteplase treatment)<br>2. Proportion of all ischemic stroke patients discharged home<br>3. Proportion of all treated (alteplase or EVT) ischemic stroke patients discharged home<br>4. Hospital length of stay for all ischemic stroke patients<br>5. Hospital length of stay for all treated (alteplase or EVT) ischemic stroke patients<br>6. Door-in-door-out times (time from hospital arrival to departure) for all patients transferred for EVT<br>7. Door to groin puncture time (time from arrival to groin puncture) for all EVT treated patients<br>8. First medical contact to needle time (time from 911 call to start of alteplase treatment)<br>9. First medical contact to groin puncture (time from 911 call to start of EVT procedure)